|
- 2019
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing PhacoemulsificationDOI: 10.1007/s40123-019-0174-x Keywords: Bromfenac, Cataract, Inflammation, Macular volume, Nepafenac, NSAIDs, Phacoemulsification, Retinal thickness, Visual acuity Abstract: Ocular inflammation grading scal
|